NYSE · Pharmaceutical Preparations

Eli Lilly and Company (LLY)

Eli Lilly and's next earnings date, recent SEC filings, insider trades and reported financials, with end-of-day prices. Every number carries its date and source.

Last close

$1,185.54

+0.13% 1 day+66.1% 52 weeks

As of Sep 28, 2026, end of day (IEX). Not a live quote.

LLY · one year of daily closes

Sep 25, 2025 to Sep 28, 2026 · end of day · IEX

LLY daily closing prices from Sep 25, 2025 to Sep 28, 2026: low $713.87, high $1,280.56, last $1,185.54. End of day, IEX.

Closing prices, split-adjusted, from trades on the IEX exchange (published the next trading day). Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Key facts

1-day change
+0.13%
From $1,183.99 the session before
52-week change
+66.1%
Close vs close ~252 sessions earlier
52-week range
$724.33–$1,280.56
Lowest and highest closing prices
Market cap
$1.12T
Last close × shares outstanding (SEC)
Revenue (TTM)
$79.7B
12 months to Jun 30, 2026
Net income (TTM)
$26.7B
12 months to Jun 30, 2026
Diluted EPS (TTM)
$29.79
12 months to Jun 30, 2026

Financials: trailing twelve months from Eli Lilly and’s reported US-GAAP figures, SEC EDGAR XBRL company facts, period ended Jun 30, 2026.

Recent SEC filings

  1. Aug 5, 202610-QQuarterly report for the period ended Jun 30, 2026
  2. Aug 5, 20268-KCurrent report: Earnings results
  3. May 20, 20268-KCurrent report: Other events
  4. May 7, 20268-KCurrent report: Shareholder vote results
  5. Apr 30, 202610-QQuarterly report for the period ended Mar 31, 2026
  6. Apr 30, 20268-KCurrent report: Earnings results
  7. Mar 20, 2026DEF 14AProxy statement for a shareholder meeting
  8. Feb 12, 202610-KAnnual report for fiscal year ended Dec 31, 2025

Source: SEC EDGAR. Each line is written from the form type and the official 8-K item titles; open the filing for the full text. All LLY filings on EDGAR

Next earnings

~Oct 29, 2026Estimated

Past results were usually filed before the open

Estimated from past filing dates. Eli Lilly and hasn't announced this date; Vero projects it from the rhythm of its past SEC filings, so treat it as approximate.

Estimated from SEC EDGAR filing dates

Insider activity (last 90 days)

Open-market buys
0
filings · 0 shares
Open-market sales
3
filings · 13,500 shares

Source: SEC EDGAR Form 4, filed in the 90 days to Oct 1, 2026. Counts are filings with at least one open-market purchase (P) or sale (S); grants, option exercises, tax withholding and gifts are left out.

Insider share counts and prices are as reported on Form 4.

With a free Vero account

What Vero tracks about Eli Lilly and

Each new Eli Lilly and filing and headline, summarized in plain English and scored 1–10 for how much it matters. Write down why you own LLY, and Vero reads every new item against those reasons: confirms, challenges or breaks. Alerts say when something crosses the line you set.

Track LLY freeWrite a thesis on LLY

The free plan follows 3 stocks, with no card and no end date.

Eli Lilly and (LLY): questions, answered from the data

When is Eli Lilly and's next earnings date?
Around Oct 29, 2026 (past results were usually filed before the open), but that is an estimate, not a date Eli Lilly and has announced. Estimated from past filing dates: Vero projects it from the dates of Eli Lilly and's past SEC filings (source: Estimated from SEC EDGAR filing dates). Treat it as approximate until the company confirms it.
What was LLY's last closing price?
LLY closed at $1,185.54 on Sep 28, 2026. This is an end-of-day price from trades on the IEX exchange, published the next trading day, not a live quote, and it can differ slightly from the consolidated official close. That was +0.13% from the session before and +66.1% over 52 weeks.
Have Eli Lilly and insiders bought or sold shares recently?
In the 90 days to Oct 1, 2026, SEC Form 4 shows 0 filings with open-market purchases (0 shares) and 3 filings with open-market sales (13,500 shares). The most recent: Jonsson Patrik (EVP & President, LLY Int'l) reported selling 6,500 shares, filed Aug 18, 2026. Grants, option exercises and tax withholding are not counted. Insider share counts and prices are as reported on Form 4.
What did Eli Lilly and file with the SEC most recently?
A 10-Q filed on Aug 5, 2026: Quarterly report for the period ended Jun 30, 2026. Before that, an 8-K on Aug 5, 2026 and an 8-K on May 20, 2026. Each filing is linked to the original on SEC EDGAR.
Is this page a recommendation to buy or sell LLY?
No. It reports public data (end-of-day prices from IEX and filings from SEC EDGAR) with the date of each. Vero is a research tool, not a financial adviser, and nothing here is a recommendation to buy or sell any security.

Related by SEC industry code

Closes are end of day (IEX), as of each page’s date. Grouped by SEC industry code (SIC).

Prices: IEX HIST end-of-day bars, published the next trading day; never live. Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Filings, Form 4 and financials: Source: SEC EDGAR. Earnings dates: Vero’s calendar, marked confirmed or estimated.

Vero is a research tool, not a financial adviser. Nothing on this site is financial advice or a recommendation to buy or sell any security.

Data as of Oct 1, 2026.